Headline
The latest stories from AHA Today.
Sens. Todd Young, R-Ind., and Debbie Stabenow, D-Mich., introduced the Social Determinants Accelerator Act, AHA-supported legislation that would provide planning grants and technical assistance to help states and communities address the social determinants of health for high-need patients.
New data from Pfizer is indicating high efficacy for its COVID-19 vaccine as a booster, as well as its effectiveness among the 5-11 age group.
Gloria Kupferman, AHA’s chief data strategy officer, describes a new benchmarking resource that gives AHA members access to aggregated, de-identified hospital data with standardized metrics on denials, reimbursement and claims processing, to use for analyzing operational and financial efficiency.
Oct. 23 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and other solid forms of prescription drugs.
The Association of University Programs in Health Administration, AHA Institute for Diversity and Health Equity, American College of Healthcare Executives, National Association of Health Services Executives, and National Association of Latino Healthcare Executives announced the Teaching Excellence…
Hospitals and health systems have worked hard to address workforce challenges as the COVID-19 surges continue, but are running out of options and need Congress’ help, writes Robyn Begley, AHA chief nursing officer and CEO of the American Organization for Nursing Leadership, in MedPage Today.
The AHA released a new COVID-19 Snapshot, underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency.
The Food and Drug Administration authorized administering a single booster dose of the Moderna and Johnson & Johnson COVID-19 vaccines to eligible individuals, and authorized eligible recipients of all three authorized COVID-19 vaccines to receive a different COVID-19 vaccine for their initial…
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted unanimously to recommend a single COVID-19 vaccine booster dose at least six months after completing an initial mRNA COVID-19 vaccine series, in the same risk groups for whom CDC recommended a Pfizer…
Learn how health care leaders such as Matthew Modica, vice president and chief information security officer at BJC HealthCare, are mitigating cyber risks as they take advantage of rapidly advancing technologies and respond to the pandemic.